PRA HEALTH SCIENCES INC - COM (PRAH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q4 2021

Type / Class: Equity / COM
Symbol: PRAH

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of PRA HEALTH SCIENCES INC - COM (PRAH) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2021 Q4	0	$0	-$1,932,000				0
2021 Q3	11,671	$1,928,000	-$10,062,066,016	$0	$0	$165.20	1
2021 Q2	61,102,953	$10,095,943,887	-$211,428,124	$2,396,000	$1,471,000	$165.21	314
2021 Q1	62,314,964	$9,554,833,526	-$6,218,157	$10,672,000	$3,450,000	$153.33	321
2020 Q4	62,485,371	$7,837,583,789	+$102,837,179	$4,867,000	$3,073,000	$125.44	280
2020 Q3	62,205,175	$6,308,850,679	+$12,251,103	$2,850,000	$6,390,000	$101.44	279
2020 Q2	62,094,172	$6,039,644,448	-$62,058,088	$2,277,000	$8,420,000	$97.29	292
2020 Q1	62,911,764	$5,219,878,235	-$37,312,351	$3,479,000	$7,542,000	$83.04	292
2019 Q4	62,916,682	$6,992,023,256	+$100,258,972	$7,120,000	$8,003,000	$111.15	341
2019 Q3	62,524,300	$6,203,572,944	-$206,444,794	$8,017,000	$15,312,000	$99.23	323
2019 Q2	64,583,473	$6,384,846,785	+$17,550,480	$33,234,000	$32,709,000	$99.15	323
2019 Q1	64,953,397	$7,160,645,816	-$53,798,228	$57,759,000	$36,208,000	$110.29	347
2018 Q4	65,536,202	$6,008,332,177	+$133,415,862	$7,649,000	$3,035,000	$91.96	329
2018 Q3	63,770,545	$7,025,720,669	-$150,671,982	$12,055,000	$5,972,000	$110.19	338
2018 Q2	65,252,204	$6,092,264,093	+$131,974,534	$7,795,000	$3,286,000	$93.36	299
2018 Q1	63,946,910	$5,303,517,865	+$124,566,108	$2,365,000	$2,332,000	$82.96	276
2017 Q4	63,348,484	$5,768,465,340	-$9,857,643	$2,642,000	$2,577,000	$91.07	280
2017 Q3	62,888,593	$4,790,210,685	+$66,176,524	$6,292,000	$1,706,000	$76.17	259
2017 Q2	62,210,861	$4,665,056,259	-$3,461,269	$13,900,000	$4,419,000	$75.01	233
2017 Q1	62,394,320	$4,069,694,182	+$240,609,372	$10,627,000	$1,074,000	$65.23	225
2016 Q4	61,094,709	$3,367,327,758	-$33,683,162	$1,313,000	$430,000	$55.12	186
2016 Q3	61,687,424	$3,484,872,614	+$31,978,048	$1,170,000	$1,921,000	$56.51	171
2016 Q2	62,228,957	$2,598,685,305	-$12,295,275	$1,815,000	$2,502,000	$41.76	162
2016 Q1	62,287,149	$2,663,299,610	+$1,597,060	$0	$2,292,000	$42.76	150
2015 Q4	62,225,151	$2,817,153,976	-$4,963,528	$412,000	$0	$45.27	120
2015 Q3	62,360,320	$2,421,448,756	+$92,588,630	$299,000	$411,000	$38.83	102
2015 Q2	60,058,767	$2,181,932,661	+$23,233,132	$254,000	$538,000	$36.33	94
2015 Q1	59,703,365	$1,721,840,249	+$14,122,488		$343,000	$28.84	72
2014 Q4	59,367,005	$1,437,868,325	+$1,436,509,325			$24.22	60